vs
太平洋生物科学（ASMB）与Broadway Financial Corp（BYFC）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Broadway Financial Corp的1.1倍（$10.8M vs $9.4M），Broadway Financial Corp净利率更高（1934.0% vs -85.2%，领先2019.2%），太平洋生物科学同比增速更快（57.6% vs 10.1%），Broadway Financial Corp自由现金流更多（$-13.0K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Virtu Financial是一家美国高频交易企业，该公司于2015年在纳斯达克完成上市，在全球金融高频交易领域开展业务。
ASMB vs BYFC — 直观对比
营收规模更大
ASMB
是对方的1.1倍
$9.4M
营收增速更快
ASMB
高出47.6%
10.1%
净利率更高
BYFC
高出2019.2%
-85.2%
自由现金流更多
BYFC
多$15.2M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $9.4M |
| 净利润 | $-9.2M | $1.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | — |
| 净利率 | -85.2% | 1934.0% |
| 营收同比 | 57.6% | 10.1% |
| 净利润同比 | 4.3% | -21.8% |
| 每股收益（稀释后） | $-0.72 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBBYFC
| Q4 25 | — | $9.4M | ||
| Q3 25 | $10.8M | $9.0M | ||
| Q2 25 | $9.6M | $8.1M | ||
| Q1 25 | $9.4M | $8.3M | ||
| Q4 24 | $7.4M | $8.6M | ||
| Q3 24 | $6.8M | $8.7M | ||
| Q2 24 | $8.5M | $8.2M | ||
| Q1 24 | $5.8M | $7.8M |
净利润ASMBBYFC
| Q4 25 | — | $1.0M | ||
| Q3 25 | $-9.2M | $-23.9M | ||
| Q2 25 | $-10.2M | $752.0K | ||
| Q1 25 | $-8.8M | $-2.7M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-9.6M | $516.0K | ||
| Q2 24 | $-11.2M | $256.0K | ||
| Q1 24 | $-9.1M | $-154.0K |
营业利润率ASMBBYFC
| Q4 25 | — | — | ||
| Q3 25 | -100.9% | -256.2% | ||
| Q2 25 | -115.2% | 12.8% | ||
| Q1 25 | -105.5% | -45.3% | ||
| Q4 24 | — | 21.7% | ||
| Q3 24 | -160.1% | 8.5% | ||
| Q2 24 | -143.0% | 4.8% | ||
| Q1 24 | -185.5% | -2.9% |
净利率ASMBBYFC
| Q4 25 | — | 1934.0% | ||
| Q3 25 | -85.2% | -264.2% | ||
| Q2 25 | -105.9% | 9.3% | ||
| Q1 25 | -93.6% | -32.3% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -140.4% | 5.9% | ||
| Q2 24 | -130.7% | 3.1% | ||
| Q1 24 | -156.9% | -2.0% |
每股收益（稀释后）ASMBBYFC
| Q4 25 | — | $0.02 | ||
| Q3 25 | $-0.72 | $-2.86 | ||
| Q2 25 | $-1.33 | $0.00 | ||
| Q1 25 | $-1.17 | $-0.39 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $-1.51 | $-0.03 | ||
| Q2 24 | $-1.98 | $0.02 | ||
| Q1 24 | $-1.66 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $10.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $262.8M |
| 总资产 | $240.0M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBBYFC
| Q4 25 | — | $10.5M | ||
| Q3 25 | $22.5M | $19.7M | ||
| Q2 25 | $24.0M | $29.5M | ||
| Q1 25 | $23.4M | $15.8M | ||
| Q4 24 | $38.3M | $61.4M | ||
| Q3 24 | $28.5M | $97.1M | ||
| Q2 24 | $19.2M | $89.8M | ||
| Q1 24 | $18.7M | $67.1M |
股东权益ASMBBYFC
| Q4 25 | — | $262.8M | ||
| Q3 25 | $182.7M | $261.7M | ||
| Q2 25 | $18.1M | $284.7M | ||
| Q1 25 | $27.1M | $283.6M | ||
| Q4 24 | $33.4M | $285.0M | ||
| Q3 24 | $26.0M | $286.2M | ||
| Q2 24 | $34.7M | $282.1M | ||
| Q1 24 | $32.6M | $281.1M |
总资产ASMBBYFC
| Q4 25 | — | $1.3B | ||
| Q3 25 | $240.0M | $1.3B | ||
| Q2 25 | $80.8M | $1.2B | ||
| Q1 25 | $99.0M | $1.3B | ||
| Q4 24 | $119.2M | $1.3B | ||
| Q3 24 | $100.3M | $1.4B | ||
| Q2 24 | $115.3M | $1.4B | ||
| Q1 24 | $119.9M | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $230.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-13.0K |
| 自由现金流率自由现金流/营收 | -140.7% | -0.1% |
| 资本支出强度资本支出/营收 | 0.4% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 0.22× |
| 过去12个月自由现金流最近4个季度 | — | $2.3M |
8季度趋势，按日历期对齐
经营现金流ASMBBYFC
| Q4 25 | — | $230.0K | ||
| Q3 25 | $-15.1M | $3.8M | ||
| Q2 25 | $-16.8M | $3.0M | ||
| Q1 25 | $-23.4M | $-4.3M | ||
| Q4 24 | $-51.1M | $1.4M | ||
| Q3 24 | $-15.2M | $6.1M | ||
| Q2 24 | $-17.1M | $9.8M | ||
| Q1 24 | $-18.4M | $-11.7M |
自由现金流ASMBBYFC
| Q4 25 | — | $-13.0K | ||
| Q3 25 | $-15.2M | $3.7M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $-4.4M | ||
| Q4 24 | $-51.1M | $1.3M | ||
| Q3 24 | — | $6.1M | ||
| Q2 24 | $-17.1M | $9.7M | ||
| Q1 24 | $-18.4M | $-11.7M |
自由现金流率ASMBBYFC
| Q4 25 | — | -0.1% | ||
| Q3 25 | -140.7% | 41.1% | ||
| Q2 25 | — | 37.0% | ||
| Q1 25 | — | -52.4% | ||
| Q4 24 | -695.2% | 14.7% | ||
| Q3 24 | — | 69.6% | ||
| Q2 24 | -200.6% | 118.9% | ||
| Q1 24 | -317.7% | -149.7% |
资本支出强度ASMBBYFC
| Q4 25 | — | 2.6% | ||
| Q3 25 | 0.4% | 1.2% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | 0.2% | 0.7% |
现金转化率ASMBBYFC
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 11.85× | ||
| Q2 24 | — | 38.21× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
